These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38158044)

  • 1. FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery.
    Wang Y; Cortes E; Huang R; Wan J; Zhao J; Hinz B; Damoiseaux R; Pushkarsky I
    SLAS Discov; 2024 Apr; 29(3):100138. PubMed ID: 38158044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors.
    Sieber P; Schäfer A; Lieberherr R; Le Goff F; Stritt M; Welford RWD; Gatfield J; Peter O; Nayler O; Lüthi U
    PLoS One; 2018; 13(11):e0207872. PubMed ID: 30485339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical stretch sustains myofibroblast phenotype and function in microtissues through latent TGF-β1 activation.
    Walker M; Godin M; Pelling AE
    Integr Biol (Camb); 2020 Sep; 12(8):199-210. PubMed ID: 32877929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.
    Huang Y; Xie Y; Abel PW; Wei P; Plowman J; Toews ML; Strah H; Siddique A; Bailey KL; Tu Y
    Biochem Pharmacol; 2020 Oct; 180():114172. PubMed ID: 32712053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression.
    Matsuzaki S; Pouly JL; Canis M
    Hum Reprod; 2023 Jan; 38(1):14-29. PubMed ID: 36413036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation.
    Dong J; Ma Q
    Part Fibre Toxicol; 2017 Jun; 14(1):18. PubMed ID: 28595626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β
    Salvarani N; Maguy A; De Simone SA; Miragoli M; Jousset F; Rohr S
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004567. PubMed ID: 28500173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation.
    Ring NAR; Volpe MC; Stepišnik T; Mamolo MG; Panov P; Kocev D; Vodret S; Fortuna S; Calabretti A; Rehman M; Colliva A; Marchesan P; Camparini L; Marcuzzo T; Bussani R; Scarabellotto S; Confalonieri M; Pham TX; Ligresti G; Caporarello N; Loffredo FS; Zampieri D; Džeroski S; Zacchigna S
    Cell Death Dis; 2021 Dec; 13(1):2. PubMed ID: 34916483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
    Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
    J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation.
    Zhou Y; Hagood JS; Lu B; Merryman WD; Murphy-Ullrich JE
    J Biol Chem; 2010 Jul; 285(29):22382-93. PubMed ID: 20463011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin modifies corneal fibroblast-to-myofibroblast differentiation.
    Chen TC; Chang SW; Wang TY
    Br J Pharmacol; 2013 Mar; 168(6):1341-54. PubMed ID: 23072440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
    Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
    J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models.
    Ilg MM; Mateus M; Stebbeds WJ; Milenkovic U; Christopher N; Muneer A; Albersen M; Ralph DJ; Cellek S
    Eur Urol; 2019 Feb; 75(2):329-340. PubMed ID: 30344087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-Rich Plasma Modulates Gap Junction Functionality and Connexin 43 and 26 Expression During TGF-β1-Induced Fibroblast to Myofibroblast Transition: Clues for Counteracting Fibrosis.
    Squecco R; Chellini F; Idrizaj E; Tani A; Garella R; Pancani S; Pavan P; Bambi F; Zecchi-Orlandini S; Sassoli C
    Cells; 2020 May; 9(5):. PubMed ID: 32408529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.